Oral phenylephrine: an ineffective replacement for pseudoephedrine?

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Allergy and Clinical Immunology

• Publication date

  2006-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JACI.2006.03.002PMID 16815167
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetics of3H-phenylephrine in man

  2004cited by this paper
• Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis.

  2002cited by this paper
• Phenylpropanolamine and the risk of hemorrhagic stroke.

  2000cited by this paper
• Selecting a Decongestant

  1993cited by this paper
• Pharmacokinetics of Oral Decongestants

  1993cited by this paper
• Pharmacokinetics of 3H-phenylephrine in man.

  1982cited by this paper
• Rhinitis medicamentosa.

  1980cited by this paper
• A System of Rhinomanometry in the Clinical Evaluation of Nasal Decongestants

  1977cited by this paper
• Oral decongestants

  1961cited by this paper

• A comment on oral phenylephrine use in sinonasal pathologies

  2025cites this paper
• Spectroscopic, quantum chemical, and topological calculations of the phenylephrine molecule using density functional theory

  2025cites this paper
• What we have learned from trying to remove oral phenylephrine from the market

  2025cites this paper
• Supporting respiratory epithelia and lowering inflammation to effectively treat common cold symptoms: A randomized controlled trial

  2024cites this paper
• Efficacy and safety of ebastine 10 mg and phenylephrine 10 mg fixed-dose combination in Indian patients with allergic rhinitis: A phase 4 multicentre study

  2024cites this paper
• Why Is Oral Phenylephrine on the Market After Compelling Evidence of Its Ineffectiveness as a Decongestant?

  2022cites this paper
• Precursor Profiling of Extracted Pseudoephedrine Using Gas Chromatography-Mass Spectrometry (GCMS) in Conjunction with Chemometric Procedure

  2021cites this paper
• Cough and Common Cold

  2021cites this paper
• Contemporary Role and Regulation of Over-the-Counter Sinonasal Medications

  2020cites this paper
• Preparation of phenylephrine 3-O-sulfate as the major in vivo metabolite of phenylephrine to facilitate its pharmacokinetic and metabolism studies.

  2019cites this paper
• Phenylephrine hydrochloride modified-release tablets for nasal congestion: a randomized, placebo-controlled trial in allergic rhinitis patients.

  2016cites this paper
• Over-the-Counter Oral Phenylephrine: A Placebo for Nasal Congestion.

  2015cites this paper
• Oral Phenylephrine HCl for Nasal Congestion in Seasonal Allergic Rhinitis: A Randomized, Open-label, Placebo-controlled Study.

  2015cites this paper
• Advances in pediatric pharmacology, therapeutics, and toxicology.

  2014cites this paper
• Recreational drug discovery: natural products as lead structures for the synthesis of smart drugs.

  2014cites this paper
• ASSESSMENT OF THE FEASIBILITY OF CO-ADMINISTRATION OF PHENOLIC DIETARY COMPOUNDS WITH PHENYLEPHRINE TO INCREASE ITS BIOAVAILABILITY

  2013cites this paper
• Computationally-designed phenylephrine prodrugs – a model for enhancing bioavailability

  2013cites this paper
• Asymmetric Hydrogenation of CO and CN Bonds in Stereoselective Synthesis

  2013cites this paper
• A Simple and Convenient Synthesis of Pseudoephedrine From N-Methylamphetamine

  2012cites this paper
• Potentiometric PVC membrane sensor for the determination of phenylephrine hydrochloride in some pharmaceutical products

  2010cites this paper
• Investigating the degradation of the sympathomimetic drug phenylephrine by electrospray ionisation-mass spectrometry.

  2010cites this paper
• Safety of fixed-dose loratadine/montelukast in subjects with allergic rhinitis.

  2010cites this paper
• Advances in pediatric pharmacology, therapeutics, and toxicology.

  2010cites this paper
• Efficacy and safety of fixed-dose loratadine/montelukast in seasonal allergic rhinitis: effects on nasal congestion.

  2009cites this paper
• Nasal decongestants for the common cold.

  2009cites this paper
• A placebo-controlled study of the nasal decongestant effect of phenylephrine and pseudoephedrine in the Vienna Challenge Chamber.

  2009cites this paper
• Efficacy of loratadine-montelukast on nasal congestion in patients with seasonal allergic rhinitis in an environmental exposure unit.

  2009cites this paper
• WITHDRAWN: Nasal decongestants for the common cold.

  2009cites this paper
• Antiallergic and Vasoactive Drugs for Allergic Rhinitis

  2009cites this paper
• Case 32. Pediatric Cough, Cold, and Fever

  2009cites this paper
• Advocating for patients through clinical research.

  2008cites this paper
• Methamphetamine precursor regulation: are we controlling or diverting the drug problem?

  2008cites this paper
• Pediatric asthma and related allergic and nonallergic diseases: patient-oriented evidence-based essentials that matter

  2008cites this paper
• Letter to the Editors Efficacy of phenylephrine

  2007cites this paper
• Efficacy of phenylephrine.

  2007cites this paper
• Meta-analysis of the efficacy of a single dose of phenylephrine 10 mg compared with placebo in adults with acute nasal congestion due to the common cold.

  2007cites this paper
• Therapeutic options for reducing sleep impairment in allergic rhinitis, rhinosinusitis, and nasal polyposis

  2007cites this paper
• An illicit reduction.

  2007cites this paper
• Efficacy of phenylephrine

  2007cites this paper
• Follow-up on the Combat Methamphetamine Epidemic Act of 2005: review of oral decongestants.

  2007cites this paper